Seeking Alpha

Pfizer confirms interest in buying AstraZeneca

  • Pfizer (PFE) offered to purchase AstraZeneca (AZN) in January for £46.61 ($76.62) a share in cash and stock, the U.S. company said, with the proposal representing a 30% premium on AstraZeneca's shares at the time.
  • After "limited high-level discussions, AstraZeneca declined to pursue negotiations," Pfizer said. The latter again contacted AstraZeneca on Saturday about a deal and the latter again "declined to engage."
  • Pfizer is now "considering its options" and will continue to offer a premium on AstraZeneca's shares, which closed at £40.80 on Friday for a market cap of £51.47B. (PR)
Comments (1)
  • Patent News
    , contributor
    Comments (1320) | Send Message
    how much is the company really worth??


    hostile takeover?
    28 Apr, 03:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: